Depression and cytokine- regulated pathways

Neurobiology of Depression

Volumn , Issue , 2011, Pages 293-316

  Baune, Bernhard T ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866691456     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (195)

1. Andreasen, N. C. 1997. Linking mind and brain in the study of mental illnesses: A project for a scientific psychopathology. Science 275 (5306):1586-93
2. Anisman, H., A. V. Ravindran, J. Griffiths, and Z. Merali. 1999. Interleukin-1 beta production in dysthymia before and after pharmacotherapy. Biol Psychiatry 46 (12):1649-55
3. Anisman, H., L. Kokkinidis, and Z. Merali. 2002. Further evidence for the depressive effects of cytokines: Anhedonia and neurochemical changes. Brain Behav Immun 16 (5):544-56
4. Apte, R. S., D. Sinha, E. Mayhew, G. J. Wistow, and J. Y. Niederkorn. 1998. Cutting edge: Role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol 160 (12):5693-6
5. Araujo, D. M., and C. W. Cotman. 1993. Trophic effects of interleukin-4,-7 and-8 on hippocampal neuronal cultures: Potential involvement of glial-derived factors. Brain Res 600 (1):49-55
6. Austin, M. P., M. Ross, C. Murray, R. E. O'Carroll, K. P. Ebmeier, and G. M. Goodwin. 1992. Cognitive function in major depression. J Affect Disord 25 (1):21-9
7. Austin, M. P., P. Mitchell, K. Wilhelm, et al. 1999. Cognitive function in depression: A distinct pattern of frontal impairment in melancholia? Psychol Med 29 (1):73-85
8. Bailey, D. J., J. J. Kim, W. Sun, R. F. Thompson, and F. J. Helmstetter. 1999. Acquisition of fear conditioning in rats requires the synthesis of mRNA in the amygdala. Behav Neurosci 113 (2):276-82
9. Baldwin, A. S., Jr. 1996. The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol 14:649-83
10. Baron, R., A. Nemirovsky, I. Harpaz, H. Cohen, T. Owens, and A. Monsonego. 2008. IFN-gamma enhances neurogenesis in wild-type mice and in a mouse model of Alzheimer's disease. FASEB J 22:2843-52
11. Baron-Cohen, S., H. A. Ring, E. T. Bullmore, S. Wheelwright, C. Ashwin, and S. C. Williams. 2000. The amygdala theory of autism. Neurosci Biobehav Rev 24 (3):355-64
12. Baune, B. T., G. Ponath, J. Golledge, et al. 2008a. Association between IL-8 cytokine and cognitive performance in an elderly general population-The MEMO-Study. Neurobiol Aging 29 (6):937-44
13. Baune, B. T., G. Ponath, M. Rothermundt, O. Riess, H. Funke, and K. Berger. 2008b. Association between genetic variants of IL-1beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study. Psychoneuroendocrinology 33 (1):68-76
14. Baune, B. T., F. Wiede, A. Braun, J. Golledge, V. Arolt, and H. Koerner. 2008c. Cognitive dysfunction in mice deficient for TNF-and its receptors. Am J Med Genet B Neuropsychiatr Genet 147B:1056-64
15. Baune, B. T., U. Dannlowski, K. Domschke, et al. 2010. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol Psychiatry 67 (6):543-9
16. Beck, R. D., Jr., M. A. King, Z. Huang, and J. M. Petitto. 2002. Alterations in septohippocampal cholinergic neurons resulting from interleukin-2 gene knockout. Brain Res 955:16-23
17. Beck, R. D., Jr., C. Wasserfall, G. K. Ha, J. D. Cushman, Z. Huang, M. A. Atkinson, and J. M. Petitto. 2005. Changes in hippocampal IL-15, related cytokines, and neurogenesis in IL-2 deficient mice. Brain Res 1041:223-30
18. Benveniste, E. N., V. T. Nguyen, and G. M. O'Keefe. 2001. Immunological aspects of microglia: Relevance to Alzheimer's disease. Neurochem Int 39 (5-6):381-91
19. Berk, M., A. A. Wadee, R. H. Kuschke, and A. O'Neill-Kerr. 1997. Acute phase proteins in major depression. J Psychosom Res 43 (5):529-34
20. Berman, D. E., S. Hazvi, K. Rosenblum, R. Seger, and Y. Dudai. 1998. Specific and differential activation of mitogen-activated protein kinase cascades by unfamiliar taste in the insular cortex of the behaving rat. J Neurosci 18 (23):10037-44
21. Bhakar, A. L., L. L. Tannis, C. Zeindler, et al. 2002. Constitutive nuclear factor-kappa B activity is required for central neuron survival. J Neurosci 22 (19):8466-75
22. Bitsch, A., T. Kuhlmann, et al. 2000. Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: Correlation with demyelinating activity and oligodendrocyte pathology. Glia 29: 366-75
23. Blaney, P. H. 1986. Affect and memory: A review. Psychol Bull 99 (2):229-46
24. Blatteis, C. M. 1990. Neuromodulative actions of cytokines. Yale J Biol Med 63 (2):133-46
25. Blum, S., A. N. Moore, F. Adams, and P. K. Dash. 1999. A mitogen-activated protein kinase cascade in the CA1/CA2 subfield of the dorsal hippocampus is essential for long-term spatial memory. J Neurosci 19 (9):3535-44
26. Bray, G. A. 2000. Afferent signals regulating food intake. Proc Nutr Soc 59 (3):373-84
27. Brebner, K., S. Hayley, R. Zacharko, Z. Merali, and H. Anisman. 2000. Synergistic effects of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha: Central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology 22 (6):566-80
28. Calvo, J. M., and A. Fernandez-Guardiola. 1984. Phasic activity of the basolateral amygdala, cingulate gyrus, and hippocampus during REM sleep in the cat. Sleep 7 (3):202-10
29. Calvo, J. M., S. Badillo, M. Morales-Ramirez, and P. Palacios-Salas. 1987. The role of the temporal lobe amygdala in ponto-geniculo-occipital activity and sleep organization in cats. Brain Res 403 (1):22-30
30. Canli, T., R. E. Cooney, P. Goldin, et al. 2005. Amygdala reactivity to emotional faces predicts improvement in major depression. Neuroreport 16 (12):1267-70
31. Capuron, L., and R. Dantzer. 2003. Cytokines and depression: The need for a new paradigm. Brain Behav Immun 17 (Suppl 1):S119-24
32. Capuron, L., and A. Ravaud. 1999. Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state. N Engl J Med 340 (17):1370
33. Carter, B. D., C. Kaltschmidt, B. Kaltschmidt, et al. 1996. Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 272 (5261):542-5
34. Castagne, V., K. Lefevre, and P. G. Clarke. 2001. Dual role of the NF-kappaB transcription factor in the death of immature neurons. Neuroscience 108 (3):517-26
35. Castanon, N., R. M. Bluthe, and R. Dantzer. 2001. Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat. Psychopharmacology (Berl ) 154 (1):50-60
36. Chen, C. H., J. Suckling, C. Ooi, et al. 2008. Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacology 33 (8):1909-18
37. Churchill, L., P. Taishi, M. Wang, et al. 2006. Brain distribution of cytokine mRNA induced by systemic administration of interleukin-1beta or tumor necrosis factor alpha. Brain Res 1120 (1):64-73
38. Connor, T. J., C. Song, B. E. Leonard, Z. Merali, and H. Anisman. 1998. An assessment of the effects of central interleukin-1beta,-2,-6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience 84 (3):923-33
39. Connor, T. J., A. Harkin, J. P. Kelly, and B. E. Leonard. 2000. Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: Effect of chronic desipramine treatment. Neuroimmunomodulation 7 (1):27-35
40. Cronholm, B., and J. O. Ottosson. 1961. Memory functions in endogenous depression before and after electroconvulsive therapy. Arch Gen Psychiatry 5:193-9
41. Danion, J. M., D. Willard-Schroeder, M. A. Zimmermann, D. Grange, J. L. Schlienger, and L. Singer. 1991. Explicit memory and repetition priming in depression. Preliminary findings. Arch Gen Psychiatry 48 (8):707-11
42. Dannlowski, U., P. Ohrmann, C. Konrad, et al. 2009. Reduced amygdala-prefrontal coupling in major depression: Association with MAOA genotype and illness severity. Int J Neuropsychopharmacol 12 (1):11-22
43. Dantzer, R., J. C. O'Connor, G. G. Freund, R. W. Johnson, and K. W. Kelley. 2008. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci 9 (1):46-56
44. Davis, M., and C. Shi. 2000. The amygdala. Curr Biol 10 (4):R131
45. Davis, M., and P. J. Whalen. 2001. The amygdala: Vigilance and emotion. Mol Psychiatry 6 (1):13-34
46. de Gelder, B., J. Vroomen, G. Pourtois, and L. Weiskrantz. 1999. Non-conscious recognition of affect in the absence of striate cortex. Neuroreport 10 (18):3759-63
47. Denicoff, KD., D. R. Rubinow, M. Z. Papa, et al. 1987. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 107 (3):293-300
48. DeRubeis, R. J., G. J. Siegle, and S. D. Hollon. 2008. Cognitive therapy versus medication for depression: Treatment outcomes and neural mechanisms. Nat Rev Neurosci 9 (10):788-96
49. Dik, M. G., C. Jonker, C. E. Hack, J. H. Smit, H. C. Comijs, and P. Eikelenboom. 2005. Serum inflammatory proteins and cognitive decline in older persons. Neurology 64 (8):1371-7
50. Dimitrov, S., T. Lange, C. Benedict, et al. 2006. Sleep enhances IL-6 trans-signaling in humans. FASEB J 20 (12):2174-6
51. DiProspero, N. A., S. Meiners, and H. M. Geller. 1997. Inflammatory cytokines interact to modulate extracellular matrix and astrocytic support of neurite outgrowth. Exp Neurol 148 (2):628-39
52. Dopp, J. M., A. Mackenzie-Graham, G. C. Otero, and J. E. Merrill. 1997. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J Neuroimmunol 75 (1-2):104-12
53. Dougherty, DD, and SL Rauch, eds. 2001. Psychiatric Neuroimaging Research; Contemporary Strategies, 1st ed. Washington, DC: American Psychiatric Press, Inc
54. Driver, J., P. Vuilleumier, M. Eimer, and G. Rees. 2001. Functional magnetic resonance imaging and evoked potential correlates of conscious and unconscious vision in parietal extinction patients. Neuroimage 14 (1 Pt 2):S68-75
55. Dunn, A. J. 2002. Mechanisms by which cytokines signal the brain. Int Rev Neurobiol 52:43-65
56. Dunn, A. J. 2006. Effects of cytokines and infections on brain neurochemistry. Clin Neurosci Res 6 (1-2):52-68
57. Dupont, R. M., T. L. Jernigan, W. Heindel, et al. 1995. Magnetic resonance imaging and mood disorders. Localization of white matter and other subcortical abnormalities. Arch Gen Psychiatry 52 (9):747-55
58. Ericsson, A., K. J. Kovacs, and P. E. Sawchenko. 1994. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 14 (2):897-913
59. Fanselow, M. S., and J. J. Kim. 1994. Acquisition of contextual Pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist d,l-2-amino-5-phosphonovaleric acid to the basolateral amygdala. Behav Neurosci 108 (1):210-12
60. Flanigan, M. J., Q. Accone, and H. P. Laburn. 1992. Amitriptyline attenuates the febrile response to a pyrogen in rabbits. J Basic Clin Physiol Pharmacol 3 (1):19-32
61. Fossati, P., G. Amar, N. Raoux, A. M. Ergis, and J. F. Allilaire. 1999. Executive functioning and verbal memory in young patients with unipolar depression and schizophrenia. Psychiatry Res 89 (3):171-87
62. Fossati, P., B. Guillaume le, A. M. Ergis, and J. F. Allilaire. 2003. Qualitative analysis of verbal fluency in depression. Psychiatry Res 117 (1):17-24
63. Frommberger, UH., J. Bauer, P. Haselbauer, A. Fräulin, D. Riemann, and M. Berger. 1997. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: Comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci 247 (4):228-33
64. Gewirtz, J. C., A. C. Chen, R. Terwilliger, R. C. Duman, and G. J. Marek. 2002. Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors. Pharmacol Biochem Behav 73 (2):317-26
65. Ghashghaei, H. T., and H. Barbas. 2002. Pathways for emotion: Interactions of prefrontal and anterior temporal pathways in the amygdala of the rhesus monkey. Neuroscience 115 (4):1261-79
66. Gold, S. M., and M. R. Irwin. 2006. Depression and immunity: Inflammation and depressive symptoms in multiple sclerosis. Neurol Clin 24 (3):507-19
67. Golinkoff, M., and J. A. Sweeney. 1989. Cognitive impairments in depression. J Affect Disord 17 (2):105-12
68. Gomes, F. C., O. Sousa Vde, and L. Romao. 2005. Emerging roles for TGF-beta1 in nervous system development. Int J Dev Neurosci 23 (5):413-24
69. Gruzelier, J., K. Seymour, L. Wilson, A. Jolley, and S. Hirsch. 1988. Impairments on neuropsychologic tests of temporohippocampal and frontohippocampal functions and word fluency in remitting schizophrenia and affective disorders. Arch Gen Psychiatry 45 (7):623-9
70. Hansen, M. K., and J. M. Krueger. 1997. Subdiaphragmatic vagotomy blocks the sleep-and fever-promoting effects of interleukin-1beta. Am J Physiol 273 (4 Pt 2):R1246-53
71. Harrison, N. A., L. Brydon, C. Walker, M. A. Gray, A. Steptoe, and H. D. Critchley. 2009. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 66 (5):407-14
72. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-kappaB. Genes Dev 18 (18):2195-224
73. He, P., Z. Zhong, et al. 2007. Deletion of tumor necrosis factor death receptor inhibits amyloid generation and prevents learning and memory deficits in Alzheimer's mice. J Cell Biol 178 (5):829-41
74. Herbert, T. B., and S. Cohen. 1993a. Depression and immunity: A meta-analytic review. Psychol Bull 113 (3):472-86
75. Herbert, TB., and S. Cohen. 1993b. Stress and immunity in humans: A meta-analytic review. Psychosom Med 55 (4):364-79
76. Hickie, I., and A. Lloyd. 1995. Are cytokines associated with neuropsychiatric syndromes in humans? Int J Immunopharmacol 17 (8):677-83
77. Holland, P. C., and M. Gallagher. 2003. Double dissociation of the effects of lesions of basolateral and central amygdala on conditioned stimulus-potentiated feeding and Pavlovian-instrumental transfer. Eur J Neurosci 17 (8):1680-94
78. Huang, Y. Y., K. C. Martin, and E. R. Kandel. 2000. Both protein kinase A and mitogen-activated protein kinase are required in the amygdala for the macromolecular synthesis-dependent late phase of long-term potentiation. J Neurosci 20 (17):6317-25
79. Hurlock, E. C. 2001. Interferons: Potential roles in affect. Med Hypotheses 56 (5):558-66
80. Ihle, J. N. 1995. The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv Immunol 60:1-35
81. Ilsley, J. E., A. P. Moffoot, and R. E. O'Carroll. 1995. An analysis of memory dysfunction in major depression. J Affect Disord 35 (1-2):1-9
82. Irwin, M., T. L. Smith, and J. C. Gillin. 1992. Electroencephalographic sleep and natural killer activity in depressed patients and control subjects. Psychosom Med 54 (1):10-21
83. Irwin, M. R., and A. H. Miller. 2007. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 21 (4):374-83
84. Jankowsky, J. L., and P. H. Patterson. 1999. Cytokine and growth factor involvement in long-term potentiation. Mol Cell Neurosci 14 (6):273-86
85. John, G. R., S. C. Lee, and C. F. Brosnan. 2003. Cytokines: Powerful regulators of glial cell activation. Neuroscientist 9 (1):10-22
86. Kang, H., and E. M. Schuman. 1996. A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity. Science 273 (5280):1402-6
87. Kaur, G., and A. K. Salm. 2008. Blunted amygdalar anti-inflammatory cytokine effector response to postnatal stress in prenatally stressed rats. Brain Res 1196:1-12
88. Kent, S., R. M. Bluthe, K. W. Kelley, and R. Dantzer. 1992. Sickness behavior as a new target for drug development. Trends Pharmacol Sci 13 (1):24-8
89. Kent, S., F. Rodriguez, K. W. Kelley, and R. Dantzer. 1994. Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat. Physiol Behav 56 (5):1031-6
90. Killgore, W. D., and D. A. Yurgelun-Todd. 2004. Activation of the amygdala and anterior cingulate during nonconscious processing of sad versus happy faces. Neuroimage 21 (4):1215-23
91. Kronfol, Z., and D. G. Remick. 2000. Cytokines and the brain: Implications for clinical psychiatry. Am J Psychiatry 157 (5):683-94
92. Kubera, M., G. Kenis, E. Bosmans, et al. 2000. Suppressive effect of TRH and imipramine on human interferon-gamma and interleukin-10 production in vitro. Pol J Pharmacol 52 (6):481-6
93. Le, Y., P. Iribarren, W. Gong, Y. Cui, X. Zhang, and J. M. Wang. 2004. TGF-beta1 disrupts endotoxin signaling in microglial cells through Smad3 and MAPK pathways. J Immunol 173 (2):962-8
94. Lee, H. J., J. S. Choi, T. H. Brown, and J. J. Kim. 2001. Amygdalar NMDA receptors are critical for the expression of multiple conditioned fear responses. J Neurosci 21 (11):4116-24
95. Levine, E. S., R. A. Crozier, I. B. Black, and M. R. Plummer. 1998. Brain-derived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-d-aspartic acid receptor activity. Proc Natl Acad Sci U S A 95 (17):10235-9
96. Licinio, J., and M. L. Wong. 1999. The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 4 (4):317-27
97. Lin, C. H., S. H. Yeh, C. H. Lin, et al. 2001. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 31 (5):841-51
98. Lu, K. T., D. L. Walker, and M. Davis. 2001. Mitogen-activated protein kinase cascade in the basolateral nucleus of amygdala is involved in extinction of fear-potentiated startle. J Neurosci 21 (16):RC162
99. Lundkvist, G. B., B. Robertson, J. D. Mhlanga, M. E. Rottenberg, and K. Kristensson. 1998. Expression of an oscillating interferon-gamma receptor in the suprachiasmatic nuclei. Neuroreport 9 (6):1059-63
100. Maes, M., E. Bosmans, H. Y. Meltzer, S. Scharpé, and E. Suy. 1993. Interleukin-1 beta: A putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry 150 (8):1189-93
101. Maes, M., N. De Vos, P. Demedts, A. Wauters, and H. Neels. 1999. Lower serum zinc in major depression in relation to changes in serum acute phase proteins. J Affect Disord 56 (2-3):189-94
102. Maes, M., L. Capuron, A. Ravaud, et al. 2001. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy. Neuropsychopharmacology 24 (2):130-40
103. Marchetti, L., M. Klein, K. Schlett, K. Pfizenmaier, and U. L. Eisel. 2004. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-d-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J Biol Chem 279 (31):32869-81
104. Mattson, M. P., and M. K. Meffert. 2006. Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ 13 (5):852-60
105. Mayberg, H. S., S. K. Brannan, R. K. Mahurin, et al. 1997. Cingulate function in depression: A potential predictor of treatment response. Neuroreport 8 (4):1057-61
106. McAfoose, J., and B. T. Baune. 2009. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 33 (3):355-66
107. McDonald, E. M., A. H. Mann, and H. C. Thomas. 1987. Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers. Lancet 2 (8569):1175-8
108. McIlroy, S. P., M. D. Vahidassr, D. A. Savage, et al. 2000. Association of serum AACT levels and AACT signal polymorphism with late-onset Alzheimer's disease in Northern Ireland. Int J Geriatr Psychiatry 15 (3):260-6
109. McMillian, M., L. Y. Kong, S. M. Sawin, et al. 1995. Selective killing of cholinergic neurons by microglial activation in basal forebrain mixed neuronal/glial cultures. Biochem Biophys Res Commun 215 (2):572-7
110. Miller, T. M., M. G. Tansey, E. M. Johnson, Jr., and D. J. Creedon. 1997. Inhibition of phosphatidylinositol 3-kinase activity blocks depolarization-and insulin-like growth factor I-mediated survival of cerebellar granule cells. J Biol Chem 272 (15):9847-53
111. Müller, N., and M. Ackenheil. 1998. Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 22 (2):1-33
112. Müller, N., E. Hofschuster, M. Ackenheil, W. Mempel, and R. Eckstein. 1993. Investigations of the cellular immunity during depression and the free interval: Evidence for an immune activation in affective psychosis. Prog Neuropsychopharmacol Biol Psychiatry 17 (5):713-30
113. Murray, E. A. 2007. The amygdala, reward and emotion. Trends Cogn Sci 11 (11):489-97
114. Musselman, DL., A. H. Miller, M. R. Porter, et al. 2001. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings. Am J Psychiatry 158 (8):1252-7
115. Nadeau, S., and S. Rivest. 2000. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor kappa B activity in the brain during endotoxemia. J Neurosci 20 (9):3456-68
116. Nader, K., G. E. Schafe, and J. E. Le Doux. 2000. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 406 (6797):722-6
117. Nadjar, A., R. M. Bluthe, M. J. May, R. Dantzer, and P. Parnet. 2005. Inactivation of the cerebral NFkappaB pathway inhibits interleukin-1beta-induced sickness behavior and c-Fos expression in various brain nuclei. Neuropsychopharmacology 30 (8):1492-9
118. Nässberger, L., and L. Träskman-Bendz. 1993. Increased soluble interleukin-2 receptor concentrations in suicide attempters. Acta Psychiatr Scand 88 (1):48-52
119. Nilsson, L. N., G. W. Arendash, R. E. Leighty, et al. 2004. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation. Neurobiol Aging 25 (9):1153-67
120. O'Brien, S. M., L. V. Scott, and T. G. Dinan. 2004. Cytokines: Abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol 19 (6):397-403
121. O'Shea, J. J., M. Gadina, and R. D. Schreiber. 2002. Cytokine signaling in 2002: New surprises in the Jak/STAT pathway. Cell 109 (Suppl):S121-31
122. Obal, F., Jr., J. Alt, P. Taishi, J. Gardi, and J. M. Krueger. 2003. Sleep in mice with nonfunctional growth hormone-releasing hormone receptors. Am J Physiol Regul Integr Comp Physiol 284 (1):R131-9
123. Pan, W., and A. Kastin. 2001. Upregulation of the transport system for TNFa at the blood-brain barrier. Arch Physiol Biochem 109 (4):350-3
124. Pare, D., G. J. Quirk, and J. E. Ledoux. 2004. New vistas on amygdala networks in conditioned fear. J Neurophysiol 92 (1):1-9
125. Parker, G. C., and D. V. Coscina. 2001. Lesions of the posterior basolateral amygdala block feeding induced by systemic 8-OH-DPAT. Pharmacol Biochem Behav 68 (4):729-34
126. Patterson, S. L., C. Pittenger, A. Morozov, et al. 2001. Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinase. Neuron 32 (z1):123-40
127. Pawlak, C. R., R. K. Schwarting, and A. Bauhofer. 2005. Cytokine mRNA levels in brain and peripheral tissues of the rat: Relationships with plus-maze behavior. Brain Res Mol Brain Res 137 (1-2):159-65
128. Peng, Y. P., Y. H. Qiu, J. H. Lu, and J. J. Wang. 2005. Interleukin-6 protects cultured cerebellar granule neurons against glutamate-induced neurotoxicity. Neurosci Lett 374 (3):192-6
129. Petrovich, G. D., and M. Gallagher. 2003. Amygdala subsystems and control of feeding behavior by learned cues. Ann N Y Acad Sci 985:251-62
130. Pezawas, L., A. Meyer-Lindenberg, E. M. Drabant, et al. 2005. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: A genetic susceptibility mechanism for depression. Nat Neurosci 8 (6):828-34
131. Phelps, E. A., and J. E. LeDoux. 2005. Contributions of the amygdala to emotion processing: From animal models to human behavior. Neuron 48 (2):175-87
132. Phillips, M. L., W. C. Drevets, S. L. Rauch, and R. Lane. 2003a. Neurobiology of emotion perception: I. The neural basis of normal emotion perception. Biol Psychiatry 54 (5):504-14
133. Phillips, M. L., W. C. Drevets, S. L. Rauch, and R. Lane. 2003b. Neurobiology of emotion perception: II. Implications for major psychiatric disorders. Biol Psychiatry 54 (5):515-28
134. Pickering, M., and J. J. O'Connor. 2007. Cytokines and their effects in the dentate gyrus. In The Dentate Gyrus: A Comprehensive Guide to Structure, Function, and Clinical Implications, ed. H. Scharfman. Progr Brain Res 163:339-54
135. Pizzagalli, D., R. D. Pascual-Marqui, J. B. Nitschke, et al. 2001. Anterior cingulate activity as a predictor of degree of treatment response in major depression: Evidence from brain electrical tomography analysis. Am J Psychiatry 158 (3):405-15
136. Plata-Salaman, C. R. 2001. Cytokines and feeding. Int J Obes Relat Metab Disord 25 (Suppl 5):S48-52
137. Pollmacher, T., M. Haack, A. Schuld, A. Reichenberg, and R. Yirmiya. 2002. Low levels of circulating inflammatory cytokines-Do they affect human brain functions? Brain Behav Immun 16 (5):525-32
138. Porter, R. J., P. Gallagher, J. M. Thompson, and A. H. Young. 2003. Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry 182:214-20
139. Quan, N., and M. Herkenham. 2002. Connecting cytokines and brain: A review of current issues. Histol Histopathol 17 (1):273-88
140. Radwanska, K., E. Nikolaev, E. Knapska, and L. Kaczmarek. 2002. Differential response of two subdivisions of lateral amygdala to aversive conditioning as revealed by c-Fos and P-ERK mapping. Neuroreport 13 (17):2241-6
141. Raison, C. L., L. Capuron, and A. H. Miller. 2006. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol 27 (1):24-31
142. Ramos, A., and P. Mormede. 1998. Stress and emotionality: A multidimensional and genetic approach. Neurosci Biobehav Rev 22 (1):33-57
143. Ransohoff, R. M., and E. N. Benveniste, eds. 2006. Cytokines and the CNS, 2nd ed. New York: Taylor & Francis Group
144. Rattiner, L. M., M. Davis, C. T. French, and K. J. Ressler. 2004. Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J Neurosci 24 (20):4796-806
145. Rattiner, L. M., M. Davis, and K. J. Ressler. 2005. Brain-derived neurotrophic factor in amygdala-dependent learning. Neuroscientist 11 (4):323-33
146. Ravnkilde, B., P. Videbech, K. Clemmensen, A. Egander, N. A. Rasmussen, and R. Rosenberg. 2002. Cognitive deficits in major depression. Scand J Psychol 43 (3):239-51
147. Reichenberg, A., R. Yirmiya, et al. 2001. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58 (5):445-52
148. Ren, K., and R. Dubner. 2007. Pain facilitation and activity-dependent plasticity in pain modulatory circuitry: Role of BDNF-TrkB signaling and NMDA receptors. Mol Neurobiol 35 (3):224-35
149. Rose, E. J., and K. P. Ebmeier. 2006. Pattern of impaired working memory during major depression. J Affect Disord 90 (2-3):149-61
150. Rosenstein, D. L., D. Lerner, and J. Cai. 1999. More on the depressive effects of interferon alfa. N Engl J Med 341 (11):849-50
151. Rothwell, N. J., and S. J. Hopkins. 1995. Cytokines and the nervous system: II. Actions and mechanisms of action. Trends Neurosci 18 (3):130-6
152. Rothwell, N. J., and S. Loddick, eds. 2002. Immune and Inflammatory Responses in the Nervous System, 2nd ed., Molecular and Cellular Neurobiology Series. New York: Oxford University Press
153. Rothwell, N. J., and J. K. Relton. 1993. Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci Biobehav Rev 17 (2):217-27
154. Saha, R. N., X. Liu, and K. Pahan. 2006. Up-regulation of BDNF in astrocytes by TNF-alpha: A case for the neuroprotective role of cytokine. J Neuroimmune Pharmacol 1 (3):212-22
155. Sakic, B., H. Szechtman, T. Braciak, C. Richards, J. Gauldie, and J. A. Denburg. 1997. Reduced preference for sucrose in autoimmune mice: A possible role of interleukin-6. Brain Res Bull 44 (2):155-65
156. Sakumoto, R., E. Kasuya, T. Komatsu, and T. Akita. 2003. Central and peripheral concentrations of tumor necrosis factor-alpha in Chinese Meishan pigs stimulated with lipopolysaccharide. J Anim Sci 81 (5):1274-80
157. Samson, R. D., and D. Pare. 2005. Activity-dependent synaptic plasticity in the central nucleus of the amygdala. J Neurosci 25 (7):1847-55
158. Schlatter, J., F. Ortuno, and S. Cervera-Enguix. 2004a. Lymphocyte subsets and lymphokine production in patients with melancholic versus nonmelancholic depression. Psychiatry Res 128 (3):259-65
159. Schlatter, J., F. Ortuno, and S. Cervera-Enguix. 2004b. Monocytic parameters in patients with dysthymia versus major depression. J Affect Disord 78 (3):243-7
160. Schleifer, S. J., S. E. Keller, and J. A. Bartlett. 1999. Depression and immunity: Clinical factors and therapeutic course. Psychiatry Res 85 (1):63-9
161. Schobitz, B., E. R. De Kloet, and F. Holsboer. 1994. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog Neurobiol 44 (4):397-432
162. Schwartz, M., A. Solomon, et al. 1991. Tumor necrosis factor facilitates regeneration of injured central nervous system axons. Brain Res 545 (1-2):334-8
163. Schwartz, M., T. Sivron, et al. 1994. Cytokines and cytokine-related substances regulating glial cell response to injury of the central nervous system. Prog Brain Res 103:331-41
164. Sei, Y., L. Vitkovic, et al. 1995. Cytokines in the central nervous system: Regulatory roles in neuronal function, cell death and repair. Neuroimmunomodulation 2 (3):121-33
165. Shen, Y., T. J. Connor, Y. Nolan, J. P. Kelly, and B. E. Leonard. 1999. Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sci 65 (17):1773-86
166. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10:405-55
167. Siegle, G. J., C. S. Carter, and M. E. Thase. 2006. Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am J Psychiatry 163 (4):735-8
168. Sluzewska, A. 1999. Indicators of immune activation in depressed patients. Adv Exp Med Biol 461:59-73
169. Sluzewska, A., J. K. Rybakowski, M. Laciak, A. Mackiewicz, M. Sobieska, and K. Wiktorowicz. 1995. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci 762:474-6
170. Smith, R. S. 1991. The macrophage theory of depression. Med Hypotheses 35 (4):298-306
171. Song, C. 2002. The effect of thymectomy and IL-1 on memory: Implications for the relationship between immunity and depression. Brain Behav Immun 16 (5):557-68
172. Spadaro, F., and A. J. Dunn. 1990. Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a novel environment. Brain Behav Immun 4 (4):308-22
173. Stefanacci, L., and D. G. Amaral. 2000. Topographic organization of cortical inputs to the lateral nucleus of the macaque monkey amygdala: A retrograde tracing study. J Comp Neurol 421 (1):52-79
174. Suen, P. C., K. Wu, E. S. Levine, et al. 1997. Brain-derived neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N-methyl-d-aspartate receptor subunit 1. Proc Natl Acad Sci U S A 94 (15): 8191-5
175. Swiergiel, A. H., and A. J. Dunn. 2006. Feeding, exploratory, anxiety-and depression-related behaviors are not altered in interleukin-6-deficient male mice. Behav Brain Res 171 (1):94-108
176. Szelenyi, J., and E. S. Vizi. 2007. The catecholamine cytokine balance: Interaction between the brain and the immune system. Ann N Y Acad Sci 1113:311-24
177. Tobinick, E. 2007. Perispinal etanercept for treatment of Alzheimer's disease. Curr Alzheimer Res 4 (5): 550-2
178. Tsvetkov, E., R. M. Shin, and V. Y. Bolshakov. 2004. Glutamate uptake determines pathway specificity of long-term potentiation in the neural circuitry of fear conditioning. Neuron 41 (1):139-51
179. Turrin, N. P., and C. R. Plata-Salaman. 2000. Cytokine-cytokine interactions and the brain. Brain Res Bull 51 (1):3-9
180. Tweedie, D., K. Sambamurti, et al. 2007. TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: New drug candidates and targets. Curr Alzheimer Res 4 (4):378-5
181. Veiel, H. O. 1997. A preliminary profile of neuropsychological deficits associated with major depression. J Clin Exp Neuropsychol 19 (4):587-603
182. Venters, H. D., Q. Tang, Q. Liu, R. W. VanHoy, R. Dantzer, and K. W. Kelley. 1999. A new mechanism of neurodegeneration: A proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci U S A 96 (17):9879-84
183. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: Intimate tales of association and dissociation. Genes Dev 9 (22):2723-35
184. Vitkovic, L., J. Bockaert, et al. 2000. "Inflammatory'' cytokines: Neuromodulators in normal brain? J Neurochem 74 (2):457-71
185. Walker, D. L., and M. Davis. 2002. The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacol Biochem Behav 71 (3):379-92
186. Weiskrantz, L. 1956. Behavioral changes associated with ablation of the amygdaloid complex in monkeys. J Comp Physiol Psychol 49 (4):381-91
187. Weisskopf, M. G., E. P. Bauer, and J. E. LeDoux. 1999. L-type voltage-gated calcium channels mediate NMDA-independent associative long-term potentiation at thalamic input synapses to the amygdala. J Neurosci 19 (23):10512-19
188. Wilson, C. J., C. E. Finch, et al. 2002. Cytokines and cognition-the case for a head-totoe inflammatory paradigm. J Am Geriatr Soc 50 (12):2041-56
189. Yamada, T., M. A. Horisberger, N. Kawaguchi, I. Moroo, and T. Toyoda. 1994. Immunohistochemistry using antibodies to alpha-interferon and its induced protein, MxA, in Alzheimer's and Parkinson's disease brain tissues. Neurosci Lett 181 (1-2):61-4
190. Yeh, S. H., C. H. Lin, C. F. Lee, and P. W. Gean. 2002. A requirement of nuclear factor-kappaB activation in fear-potentiated startle. J Biol Chem 277 (48):46720-9
191. Yeh, S. H., C. H. Lin, and P. W. Gean. 2004. Acetylation of nuclear factor-kappaB in rat amygdala improves long-term but not short-term retention of fear memory. Mol Pharmacol 65 (5):1286-92
192. Yeh, T. C., and S. Pellegrini. 1999. The Janus kinase family of protein tyrosine kinases and their role in signaling. Cell Mol Life Sci 55 (12):1523-34
193. Yin, L., L. Wu, H. Wesche, et al. 2001. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science 291 (5511):2162-5
194. Yirmiya, R. 1996. Endotoxin produces a depressive-like episode in rats. Brain Res 711 (1-2):163-74
195. Zorrilla, E. P., L. Luborsky, J. R. McKay, et al. 2001. The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain Behav Immun 15 (3):199-226